HomeAI · summaries
Storia in 4 fonti
Breakthrough offers new hope for patients with relapsed blood cancer
Two late-stage trials presented at ASCO show major advances for patients with relapsed multiple myeloma, including an oral drug that doubled disease-control time and an immunotherapy that sharply reduced progression and death risk
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
medicalxpress.com
Teclistamab extends remission in relapsed myeloma, with 70% progression-free at 18 months
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in remission far longer than those receiving standard…
- ·
hurriyetdailynews.com
Trial offers fresh hope for patients resistant to standard cancer treatments - World News
A new cancer treatment tested in patients who had exhausted existing options has delivered what researchers are calling unprecedented results, raising fresh hopes for people with…
- ·
pharmaceutical-technology.com
ASCO26: BMS and J&J debut shining multiple myeloma data - Pharmaceutical Technology
Both BMS and J&J touted positive data for their multiple myeloma drugs at ASCO 2026.
- ·
ynetnews.com
Breakthrough offers new hope for patients with relapsed blood cancer
Two late-stage trials presented at ASCO show major advances for patients with relapsed multiple myeloma, including an oral drug that doubled disease-control time and an…